C.R. Freeman
Impact in
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
- Gastroenterology top 2%
- Gastrointestinal Tumor Research and Treatment
Papers in
-
- Sarcoma Diagnosis and Treatment 1
- Prostate Cancer Treatment and Research 1
- Radiation Therapy and Dosimetry 1
-
- Soft tissue tumors and treatment 1
- Lymphoma Diagnosis and Treatment 1
- Co-authors
- Sidney J. Cutler (3 shared papers)John W. Berg (1 shared paper)Maurice M. Black (2 shared papers)T Mørk (2 shared papers)Sverre Harvei (2 shared papers)V. Benk (1 shared paper)Carey Levinton (1 shared paper)Jeffrey P. Krischer (1 shared paper)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (4 papers)Cancer (3 papers)Clinical Cancer Research (1 paper)Radiotherapy and Oncology (1 paper)
- Partner nations
- NorwayUnited StatesCanada
In The Last Decade
C.R. Freeman
7 papers receiving 1.9k citations
C.R. Freeman's Hit Papers
Peers
Comparison fields: 5 of 64
- Pathology and Forensic Medicine 1.5k
- Gastroenterology 146
- Oncology 720
- Neurology 376
- Genetics 212
Countries citing papers authored by C.R. Freeman
This map shows the geographic impact of C.R. Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.R. Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.R. Freeman more than expected).
Fields of papers citing papers by C.R. Freeman
This network shows the impact of papers produced by C.R. Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.R. Freeman. The network helps show where C.R. Freeman may publish in the future.
Co-authors
The 21 scholars most cited alongside C.R. Freeman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Occurrence and prognosis of extranodal lymphomas Hit paper breakdown → | 1972 | 1769 |
| 2 | 1971 | 131 | |
| 3 | 1969 | 127 | |
| 4 | 1999 | 8 | |
| 5 | 1992 | 5 | |
| 6 | 1999 | 2 | |
| 7 | PI-88, a heparanase inhibitor showing promising evidence of patient benefit in phase II clinical trials. | 2005 | 1 |
| 8 | 2005 | 1 | |
| 9 | 2012 | 0 |
About C.R. Freeman
C.R. Freeman is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Oncology, Radiation and Cancer Research, having authored 9 papers that have together received 2.0k indexed citations. Recurring topics across this work include Advanced Radiotherapy Techniques (2 papers), Breast Cancer Treatment Studies (2 papers), Sarcoma Diagnosis and Treatment (1 paper), Soft tissue tumors and treatment (1 paper), Prostate Cancer Treatment and Research (1 paper), Radiation Therapy and Dosimetry (1 paper), Lymphoma Diagnosis and Treatment (1 paper) and Soft tissue tumor case studies (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (1.5k citations), Gastroenterology (146 citations), Oncology (720 citations), Neurology (376 citations) and Genetics (212 citations). C.R. Freeman has collaborated with scholars based in Norway, United States and Canada. Frequent co-authors include Sidney J. Cutler, John W. Berg, Maurice M. Black, T Mørk, Sverre Harvei, V. Benk, Carey Levinton, Jeffrey P. Krischer, William Parker and Vivian Ho. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Cancer, Clinical Cancer Research and Radiotherapy and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.